A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)
Conditions: Pneumococcal Infection Interventions: Biological: V116; Biological: PPSV23 Sponsors: Merck Sharp& Dohme LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Children | Meningitis Vaccine | Merck | Pneomococcal Vaccine | Research | Study | Vaccines